Athersys-Pfizer Investors: Anticipating A Phase III Trial For Inflammatory Bowel Dise

Athersys, Inc. and Pfizer, Inc. , after starting out with carefully chosen steps, are nearing completion of a phase II trial for investigating a potential new treatment for Inflammatory Bowel Disease .


More...